Stockscreener 앱 받기
26.24
2.05%
-0.55
시간 외 거래:
25.60
-0.64
-2.44%
전일 마감가:
$26.79
열려 있는:
$26.89
하루 거래량:
1.31M
Relative Volume:
1.16
시가총액:
$2.30B
수익:
$23.38M
순이익/손실:
$-155.22M
주가수익비율:
-11.98
EPS:
-2.19
순현금흐름:
$-134.36M
1주 성능:
-5.07%
1개월 성능:
+6.19%
6개월 성능:
+66.39%
1년 성능:
-13.11%
1일 변동 폭
$26.05
$26.96
1주일 범위
$26.05
$28.39
52주 변동 폭
$13.45
$32.67
Ideaya Biosciences Inc Stock (IDYA) Company Profile
명칭
Ideaya Biosciences Inc
전화
650-443-6209
주소
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
IDYA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IDYA
Ideaya Biosciences Inc
|
26.24 | 2.35B | 23.38M | -155.22M | -134.36M | -2.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-18 | 개시 | Guggenheim | Buy |
| 2025-09-04 | 개시 | Barclays | Overweight |
| 2025-09-04 | 개시 | Citizens JMP | Mkt Outperform |
| 2025-07-22 | 개시 | TD Cowen | Buy |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2025-06-26 | 개시 | Wells Fargo | Overweight |
| 2024-11-18 | 개시 | Stephens | Overweight |
| 2024-11-05 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-10-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-07-08 | 개시 | Mizuho | Outperform |
| 2024-03-08 | 개시 | BTIG Research | Buy |
| 2023-08-08 | 개시 | SVB Securities | Outperform |
| 2023-05-24 | 개시 | Goldman | Buy |
| 2023-04-24 | 업그레이드 | Stifel | Hold → Buy |
| 2023-03-23 | 개시 | Berenberg | Buy |
| 2023-02-28 | 개시 | RBC Capital Mkts | Outperform |
| 2022-12-28 | 개시 | CapitalOne | Overweight |
| 2022-10-27 | 개시 | Citigroup | Buy |
| 2022-08-15 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2022-03-10 | 업그레이드 | Stifel | Hold → Buy |
| 2021-09-23 | 개시 | Stifel | Hold |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2021-03-11 | 개시 | Guggenheim | Buy |
| 2020-10-07 | 개시 | Wedbush | Outperform |
| 2020-09-01 | 개시 | Northland Capital | Outperform |
| 2020-07-13 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-06-17 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-06 | 개시 | H.C. Wainwright | Buy |
| 2020-03-13 | 개시 | ROTH Capital | Buy |
| 2019-10-17 | 개시 | Oppenheimer | Outperform |
| 2019-09-10 | 개시 | Robert W. Baird | Outperform |
| 2019-06-17 | 개시 | Citigroup | Buy |
| 2019-06-17 | 개시 | JP Morgan | Neutral |
| 2019-06-17 | 개시 | Jefferies | Buy |
모두보기
Ideaya Biosciences Inc 주식(IDYA)의 최신 뉴스
Can IDEAYA Biosciences Inc. stock maintain growth trajectoryTrade Volume Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Is IDEAYA Biosciences Inc. showing signs of accumulationJuly 2025 Sentiment & Expert Curated Trade Ideas - newser.com
Has IDEAYA Biosciences Inc. formed a bullish divergenceStop Loss & Weekly Top Stock Performers List - newser.com
IDEAYA Biosciences' (IDYA) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
IDEAYA Biosciences Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
J.P. Morgan Remains Bullish on IDEAYA Biosciences (IDYA) - Yahoo
Ideaya Biosciences stock maintains Market Outperform rating at Citizens - Investing.com
How IDEAYA Biosciences Inc. (30J) stock compares with market leaders2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
IDEAYA Biosciences Inc. stock outlook for YEARTrade Volume Report & Reliable Intraday Trade Alerts - newser.com
IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss - MSN
Is IDEAYA Biosciences Inc. stock bottoming outPrice Action & Weekly Market Pulse Alerts - newser.com
Can momentum traders help lift IDEAYA Biosciences Inc.July 2025 Weekly Recap & Safe Swing Trade Setups - newser.com
IDEAYA Biosciences (NASDAQ:IDYA) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Price action breakdown for IDEAYA Biosciences Inc.July 2025 Trade Ideas & AI Based Buy and Sell Signals - newser.com
Using Bollinger Bands to evaluate IDEAYA Biosciences Inc.CEO Change & Weekly Momentum Picks - newser.com
Will IDEAYA Biosciences Inc. stock split again soonInflation Watch & Technical Pattern Alert System - newser.com
Long term hold vs stop loss in IDEAYA Biosciences Inc.2025 Risk Factors & AI Based Buy and Sell Signals - newser.com
Platinum Investment Management Ltd. Has $3.51 Million Stake in IDEAYA Biosciences, Inc. $IDYA - MarketBeat
Combining price and volume data for IDEAYA Biosciences Inc.Weekly Stock Summary & Daily Volume Surge Signals - newser.com
IDEAYA Biosciences to Participate in Upcoming May 2025 Investor Relations Events - 富途牛牛
What to do if you’re stuck in IDEAYA Biosciences Inc.M&A Rumor & Fast Entry High Yield Stock Tips - newser.com
What drives IDEAYA Biosciences Inc stock priceHealthcare Stock Analysis & Minimal Investment Trading Plans - earlytimes.in
Voya Investment Management LLC Has $377,000 Stock Position in IDEAYA Biosciences, Inc. $IDYA - MarketBeat
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Eastern Progress
IDEAYA Biosciences to Participate in Upcoming February 2025 Investor Relations Events - The Malaysian Reserve
Ideaya Biosciences announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
JPMorgan Anticipates Positive Developments for Ideaya Biosciences (IDYA) - GuruFocus
J.P. Morgan Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Maintains Target Price $74 - 富途牛牛
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
UBS reiterates Buy rating on Ideaya Biosciences stock with $50 target - Investing.com
Guggenheim Begins Coverage on IDEAYA Biosciences (NASDAQ:IDYA) - MarketBeat
Rhumbline Advisers Boosts Holdings in IDEAYA Biosciences, Inc. $IDYA - MarketBeat
Ideaya Biosciences Inc (IDYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):